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Acute increase of α-synuclein inhibits synaptic 
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Austin, Austin, TX 78712; bEugene Bell Center for Regenerative Biology and Tissue Engineering, Marine Biological 
Laboratory, Woods Hole, MA 02543; cDepartment of Cell and Developmental Biology, University of Illinois, Urbana, IL 
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ABSTRACT Parkinson’s disease is associated with multiplication of the α-synuclein gene and 
abnormal accumulation of the protein. In animal models, α-synuclein overexpression broadly 
impairs synaptic vesicle trafficking. However, the exact steps of the vesicle trafficking path-
way affected by excess α-synuclein and the underlying molecular mechanisms remain un-
known. Therefore we acutely increased synuclein levels at a vertebrate synapse and per-
formed a detailed ultrastructural analysis of the effects on presynaptic membranes. At 
stimulated synapses (20 Hz), excess synuclein caused a loss of synaptic vesicles and an expan-
sion of the plasma membrane, indicating an impairment of vesicle recycling. The N-terminal 
domain (NTD) of synuclein, which folds into an α-helix, was sufficient to reproduce these ef-
fects. In contrast, α-synuclein mutants with a disrupted N-terminal α-helix (T6K and A30P) 
had little effect under identical conditions. Further supporting this model, another α-synuclein 
mutant (A53T) with a properly folded NTD phenocopied the synaptic vesicle recycling de-
fects observed with wild type. Interestingly, the vesicle recycling defects were not observed 
when the stimulation frequency was reduced (5 Hz). Thus excess α-synuclein impairs synaptic 
vesicle recycling evoked during intense stimulation via a mechanism that requires a properly 
folded N-terminal α-helix.
INTRODUCTION
Parkinson’s disease (PD) is an age-related movement disorder asso-
ciated with the aberrant aggregation of α-synuclein and formation 
of Lewy bodies (Spillantini et al., 1998; Lee and Trojanowski, 2006). 
Familial PD is linked to α-synuclein overexpression, caused by mul-
tiplication of the α-synuclein gene (SNCA), and to several missense 
mutations, including A30P and A53T (Polymeropoulos et al., 1997; 
Kruger et al., 1998; Singleton et al., 2003; Zarranz et al., 2004; 
Dawson et al., 2010). Sporadic PD is also associated with increased 
α-synuclein expression (Chiba-Falek et al., 2006; Dumitriu et al., 
2012), as is dementia with Lewy bodies (DLB; Surguchov, 2008). 
Thus examining the function of α-synuclein and the consequences 
of its overexpression is a means for understanding the pathobiology 
underlying several neurological diseases.
α-Synuclein is a small protein (aa 140) found at neuronal syn-
apses (Maroteaux et al., 1988; Murphy et al., 2000; Bendor et al., 
2013). It is naturally disordered in an aqueous environment (Davidson 
et al., 1998; Eliezer et al., 2001). However, when presented with 
negatively charged acidic phospholipids in small vesicles, the N-
terminal domain (NTD) of α-synuclein (aa 1–110) binds and folds 
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not yet been performed, due to limitations in most experimental 
models.
We therefore took advantage of a model vertebrate synapse, the 
lamprey giant reticulospinal (RS) synapse, which is uniquely suited 
for these experiments and meets all of the above criteria. Lamprey 
RS synapses allow for acute perturbations of presynaptic proteins, 
detailed high-resolution ultrastructural analyses of presynaptic 
membranes, and rapid investigation of mutants through axonal in-
jection of recombinant proteins. Furthermore, over the past two de-
cades, studies performed at the RS synapses have yielded many 
fundamental insights into the molecular mechanisms of synaptic 
vesicle trafficking (Pieribone et al., 1995; Shupliakov et al., 1997; 
Brodin and Shupliakov, 2006). In this paper, we report that excess 
α-synuclein and a PD-linked mutant, A53T, inhibit synaptic vesicle 
recycling from the plasma membrane during high-frequency stimu-
lation, and we provide evidence for the underlying structural 
mechanisms.
RESULTS
Synucleins are highly conserved from lampreys to humans
Before beginning the synapse studies, we characterized the synu-
cleins in sea lamprey, Petromyzon marinus. We cloned three synu-
clein isoforms from lamprey: two γ-synucleins and a third isoform 
that has not yet been assigned (Busch and Morgan, 2012). Lamprey 
giant RS neurons, which give rise to the synapses of interest, abun-
dantly expressed only one of the γ-synuclein isoforms (GenBank: 
JN544525), while the other isoforms were expressed at very low 
levels (Busch and Morgan, 2012). Multiple sequence alignment re-
veals that full-length lamprey γ-synuclein shares 56, 54, and 55% 
identity at the amino acid level with human α-, β-, and γ-synucleins, 
respectively (Figure 1A). The first 90 amino acids at the N-termini of 
lamprey γ-synuclein and human α-synuclein share even greater ho-
mology at 67% identity and 90% similarity, as this is the most con-
served region among all synucleins (Figure 1A; George, 2002). In 
contrast, the C-termini of all synucleins are notably less conserved, 
such that human β- and γ-synuclein share only 61 and 47% identity 
with α-synuclein. Thus lamprey γ-synuclein shares a degree of ho-
mology with human α-synuclein that is comparable to the homol-
ogy between human synuclein orthologues.
Comparative sequence analysis software (3D-JIGSAW, version 
2.0) predicts that the NTD of lamprey γ-synuclein folds into an ex-
tended α-helix, followed by a less structured, random coil at the 
C-terminus, similar to the structure of human α-synuclein bound to 
lipid micelles (Figure 1B; Ulmer et al., 2005). As another indicator 
of structural conservation, recombinant human and lamprey synu-
cleins were all recognized by the same pan-synuclein antibody 
raised against a highly conserved epitope within the N-terminus of 
human α-synuclein (aa 19–41; Figure 1, A, C, and D). This antibody 
also recognized endogenous rat and lamprey synucleins (Figure 1, 
E and F). Similar to human α-synuclein (Davidson et al., 1998; 
Perrin et al., 2000), full-length lamprey γ-synuclein and its NTD (aa 
1–89) bound to small unilamellar vesicles (suvs) containing a mix-
ture of phosphatidylcholine (PC) and phosphatidic acid (PA), but 
remained as free protein in the presence of suvs containing only 
PC (Figure 1G; n = 2). Lamprey γ-synuclein did not bind to large, 
multilamellar vesicles (Figure 1G). Thus, as with human α-synuclein, 
lamprey γ-synuclein demonstrates a preference for binding to 
acidic phospholipids, but only when they are presented in highly 
curved surfaces such as small vesicles. These data demonstrate 
that lamprey γ-synuclein and human α-synuclein are highly con-
served, which predicts that they will cause similar synaptic 
phenotypes.
into an amphipathic α-helix (Davidson et al., 1998; Perrin et al., 
2000; Chandra et al., 2003; Ulmer et al., 2005). Immunostaining of 
the endogenous protein reveals that α-synuclein is abundant at 
synapses, where it colocalizes with presynaptic vesicle clusters 
(Maroteaux et al., 1988; Murphy et al., 2000).
Because α-synuclein is found at synapses under physiological 
conditions and because its overexpression is linked to several dis-
eases, there is a growing interest in understanding how α-synuclein 
affects synaptic structure and function. In mouse models of PD and 
in DLB patients, a large fraction of α-synuclein aggregates occur in 
presynaptic boutons (Kramer and Schulz-Schaeffer, 2007; Scott 
et al., 2010; Spinelli et al., 2014). Furthermore, synaptic defects 
caused by the overexpression of α-synuclein can precede α-synuclein 
aggregation in somata and the formation of Lewy bodies, poten-
tially implicating the synaptic impairments in early stages of disease 
pathogenesis (Scott et al., 2010; Volpicelli-Daley et al., 2011). 
Chronic overexpression of human α-synuclein broadly impairs syn-
aptic vesicle trafficking and results in the down-regulation or loss of 
several other presynaptic proteins (Larsen et al., 2006; Nemani et al., 
2010; Scott et al., 2010; Scott and Roy, 2012; Gaugler et al., 2012). 
These growing connections between α-synuclein and synaptic dys-
function indicate a need for gaining a deeper understanding of the 
underlying mechanisms.
Although it is has been shown that chronic overexpression of α-
synuclein impairs synaptic vesicle trafficking (Nemani et al., 2010; 
Scott et al., 2010), there are several outstanding questions that war-
rant further investigation. First, the direct effects of excess α-
synuclein on synapses remain unclear, because chronic overexpres-
sion decreased the expression levels of several other presynaptic 
proteins, including those that regulate synaptic vesicle exocytosis 
(e.g., VAMP and complexin), endocytosis (e.g., amphiphysin), and 
vesicle clustering and reclustering (e.g., synapsin) (Nemani et al., 
2010; Scott et al., 2010). As a consequence, overexpression of 
α-synuclein may lead to compensatory phenotypes that mask its 
direct effects on vesicle trafficking or cause a complex phenotype 
that is only partially related to α-synuclein. Overcoming these issues 
requires that excess synuclein be delivered acutely to synapses and 
the effects examined after a short time and before compensatory 
changes take place. Second, the precise steps of the vesicle traffick-
ing pathway affected by excess α-synuclein are unclear. After exocy-
tosis and neurotransmitter release, synaptic vesicles are locally re-
cycled by endocytosis from the plasma membrane (Schweizer and 
Ryan, 2006; Morgan et al., 2013a). One pathway for recycling vesi-
cles occurs via clathrin-mediated endocytosis, which proceeds 
through several morphologically and molecularly distinct stages 
(Heuser and Reese, 1973; Slepnev and De Camilli, 2000; Saheki and 
De Camilli, 2012). At high levels of stimulation, synaptic vesicles can 
also be recycled via activity-dependent bulk endocytosis (Cousin, 
2009; Morgan et al., 2013a). SynaptopHluorin assays revealed that 
α-synuclein overexpression reduced the recycling pool of synaptic 
vesicles, suggesting endocytic defects (Nemani et al., 2010). How-
ever, whether α-synuclein is affecting early or late endocytosis, 
clathrin-mediated or bulk endocytosis or both, remains an open 
question that requires detailed ultrastructural analyses of presynap-
tic membranes under controlled stimulation conditions. Finally, the 
structural mechanism by which excess α-synuclein impairs synapses 
is unclear. Which domain of synuclein is responsible for causing the 
phenotypes? Is it the disordered or α-helical conformation of the 
protein that causes deleterious effects at synapses? Answering these 
questions requires the ability to perform a structure–function analy-
sis of multiple α-synuclein mutants. These types of acute perturba-
tions, combined with ultrastructural and mutational analyses, have 
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presynaptic vesicle clusters in all vertebrates examined, including 
lampreys (Buckley and Kelly, 1985; Lau et al., 2011). Synuclein colo-
calized with SV2 in synaptic puncta throughout the lamprey spinal 
cord (Figure 2, B–G). The Pearson’s correlation coefficient for the 
immunofluorescence signals was 0.78 ± 0.04, indicating robust co-
localization of synuclein with SV2 at synapses (n = 5 images, four ani-
mals). Furthermore, synuclein colocalized with SV2 at the giant RS 
synapses, which contain ∼1000 synaptic vesicles per cluster and are 
located at the periphery of the giant axons (Figure 2, E–G). Thus 
synuclein is endogenously expressed at lamprey giant RS synapses, 
Synuclein is expressed at lamprey RS synapses
Lamprey RS synapses are large, en passant glutamatergic synapses 
formed between the descending giant RS axons in the ventromedial 
tract of the spinal cord and several types of intraspinal neurons 
(Figure 2A; Rovainen, 1974; Wickelgren et al., 1985; Buchanan, 
2001). Before studying the acute effects of excess synuclein on syn-
aptic vesicle trafficking, we wanted to examine the endogenous ex-
pression of synuclein in the lamprey spinal cord. Cross-sections of 
spinal cord were double labeled with antibodies against synuclein 
and synaptic vesicle glycoprotein 2 (SV2), a reliable marker of 
FIGURE 1: Lamprey γ-synuclein is structurally similar to human α-synuclein. (A) Multiple sequence alignment of human 
synucleins (α, β, γ) and lamprey γ-synuclein. Black highlighted residues are those that are identical to human α-synuclein. 
Note the higher degree of similarity within the NTDs of all synucleins (aa 1–90; backlit in gray). Black lines indicate the 
11-amino-acid repeats that characterize all synucleins and that fold into an α-helix. Epitope of the pan-synuclein 
antibody used in this study is indicated. (B) Top, solution NMR structure of human α-synuclein bound to detergent 
micelles (Ulmer et al., 2005); bottom, the predicted structure of lamprey γ-synuclein. Ribbon models were generated 
using University of California–San Francisco Chimera modeling software. (C and D) A pan-synuclein antibody generated 
against human α-synuclein recognizes all three recombinant human synucleins and GST-tagged lamprey γ-synuclein, 
indicating structural conservation. The antibody does not recognize GST alone. Top panels are the Western blots 
against synuclein (WB:Syn); bottom panels are Coomassie-stained (Coom) gels of the same proteins. (E and F) In rat 
brain lysates and in lamprey spinal cord (SC) and brain lysates, the pan-synuclein antibody recognizes an endogenous 
17-kDa protein—the expected size for monomeric synuclein. (G) GST-tagged lamprey γ-synuclein and its NTD (Nterm) 
bind to suvs containing PC and PA in a 3:1 M ratio, but not to PC alone (n = 2). Neither the C-terminal domain (Cterm) of 
lamprey synuclein nor GST alone binds PC/PA, but instead remain as free protein. No binding to multilamellar vesicles 
(mlv) was observed.
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within the isolated spinal cord, giant RS axons do not fire action 
potentials unless they are stimulated; furthermore, giant RS 
synapses have low spontaneous release rates, making the resting 
synapses relatively quiescent (Brodin et al., 1994).
To determine the effect of excess synuclein on unstimulated syn-
apses, we microinjected glutathione S-transferase (GST)-tagged 
full-length lamprey γ-synuclein into giant RS axons, thereby intro-
ducing it directly to the presynapse (Figure 3, A and B). We also 
examined the effects of lamprey γ-synuclein NTD, since this is the 
most highly conserved region of all synucleins (Figure 3B). We esti-
mate the axonal concentration of the injected proteins to be in the 
range of 6–20 μM (see Material and Methods), which is ∼2–5 times 
greater than the estimated amount of endogenous synuclein at syn-
apses and is commensurate with synuclein overexpression in animal 
models of PD (Nemani et al., 2010; Westphal and Chandra, 2013). 
At unstimulated synapses, excess GST, full-length lamprey 
γ-synuclein, and NTD did not cause any obvious structural changes 
to presynaptic vesicle clusters when compared with synapses from 
uninjected control axons (Figure 3, C–F). In all cases, the synaptic 
vesicle clusters remained large and tightly clustered around the ac-
tive zone, the electron-dense contact between the presynaptic axon 
and postsynaptic dendrite where neurotransmitter release occurs. A 
quantitative analysis across synapses revealed no significant differ-
ence in the size of the synaptic vesicle (SV) clusters between these 
conditions (Figure 3G; uninjected controls: 131 ± 12 SVs/section, 
n = 12 synapses, 4 axons; GST: 103 ± 9 SVs/section, n = 13 synapses, 
2 axons; GST-synuclein: 139 ± 22 SVs/section, n = 11 synapses, 
2 axons; GST-synuclein NTD: 101 ± 13 SVs/section, n = 8 synapses, 
2 axons; analysis of variance [ANOVA] p = 0.18). Thus excess synu-
clein did not affect synaptic vesicle clustering at resting, unstimu-
lated synapses, indicating that vesicle declustering is not the mech-
anism by which synuclein disrupts synaptic vesicle trafficking.
Excess lamprey γ-synuclein impairs synaptic vesicle recycling 
evoked during intense stimulation
Next we examined whether excess synuclein affects synaptic vesicle 
trafficking at stimulated synapses. By combining the acute introduc-
tion of excess synuclein with controlled stimulation conditions and 
ultrastructural analyses, we could determine for the first time the 
exact stages of synaptic vesicle trafficking directly affected by 
increased levels of synuclein. We repeated the injections of GST, 
lamprey γ-synuclein, and NTD. But this time we stimulated the ax-
ons with action potentials at high frequency (20 Hz, 5 min) to induce 
synaptic vesicle exocytosis and endocytosis. Though this is a strong 
stimulus, the RS neurons can fire steadily or burst in vivo at 10–20 Hz 
(Di Prisco et al., 2000; Dubuc et al., 2008). After 20-Hz stimulation, 
GST-treated synapses still exhibited large synaptic vesicle clusters, 
and the plasma membrane adjacent to the active zone became 
slightly evaginated (Figure 4A). Plasma membrane evaginations oc-
cur at stimulated synapses, because vesicle endocytosis from the 
plasma membrane is slower than exocytosis (Morgan et al., 2004; 
von Kleist et al., 2011). Thus, with GST, endocytosis is sufficient for 
maintaining large synaptic vesicle clusters.
However, when stimulated synapses were treated with full-length 
lamprey γ-synuclein, there was a dramatic effect on presynaptic 
morphology. Specifically, there was a massive loss of synaptic vesi-
cles and an increase in large, atypical, irregularly shaped membrane 
compartments, which we refer to as “cisternae,” in keeping with 
previous studies (Figure 4B; Heuser and Reese, 1973; Andersson 
et al., 2008). The most common cisternae were irregular and vesicu-
lar in nature (Figure 4D, top). However, cisternae sometimes 
appeared as flattened sacs or tubules (Figure 4D, bottom), which is 
providing a unique opportunity to investigate the acute effects of 
excess synuclein on synaptic vesicle trafficking.
Excess lamprey γ-synuclein has no effect on vesicle 
clustering at unstimulated synapses
The vesicle trafficking defects observed at mammalian synapses af-
ter overexpression of human α-synuclein could be explained, in 
theory, by primary disruptions in synaptic vesicle clustering. For ex-
ample, if excess synuclein caused the synaptic vesicles to become 
declustered and move away from the synaptic contact, then this 
would reduce the total number of vesicles immediately available for 
exocytosis and endocytosis, resulting in impaired vesicle trafficking. 
To determine this unequivocally requires examining the effects of 
excess synuclein on vesicle clusters when the synapses are inactive. 
Here the lamprey RS synapses provide an advantage, because 
FIGURE 2: Synuclein is localized to synaptic vesicle clusters at lamprey 
giant RS synapses. (A) Top, cross-section of a lamprey spinal cord 
stained with toluidine blue. Note the giant RS axons in the 
ventromedial tract. The box marks a single giant RS axon and the view 
shown in B–D. D, dorsal; V, ventral. Bottom, insets show the location of 
giant RS synapses along the periphery of the giant axons. SVs, synaptic 
vesicles. Asterisk marks postsynaptic dendrite. (B–G) Immunolabeling 
of synuclein (green) and SV2 (red) in the lamprey spinal cord. Merged 
image reveals strong colocalization between synuclein and SV2, 
indicating synuclein’s localization at synaptic vesicle clusters (Pearson’s 
colocalization coefficient = 0.78 ± 0.04; n = 5). Dotted line indicates the 
border of the giant RS axon. Arrows indicate RS synapses, which are 
shown in high magnification in panels E–G. Puncta outside the dotted 
line are synapses formed by smaller intraspinal axons within the 
neuropil. Scale bar in B is 20 μm and applies to panels B–D. Scale bar 
in E is 5 μm and applies to panels E–G.
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noteworthy, because α-synuclein was recently shown to have the 
ability to tubulate lipid membranes (Westphal and Chandra, 2013). 
Clathrin-coated pits were often observed emanating from the cister-
nae (Figure 4, B and D). Interestingly, the NTD of lamprey γ-synuclein 
produced a similar phenotype (Figure 4C). Quantitative analysis re-
vealed that both full-length lamprey γ-synuclein and NTD caused a 
significant reduction in the number of synaptic vesicles per synapse 
compared with GST controls (Figure 4E; GST: 82 ± 20 SVs/section, 
n = 13 synapses, 2 axons; GST-synuclein: 33 ± 4 SVs/section, n = 35 
synapses, 3 axons; GST-synuclein NTD: 8 ± 1 SVs, n = 13 synapses, 
2 axons; ANOVA p < 0.00005). The remaining synaptic vesicles had 
the same diameter as in controls (GST: 50.2 ± 0.5 nm, n = 
200 SVs; GST-synuclein: 48.5 ± 0.6 nm, n = 200 SVs; GST-synuclein 
NTD: 50.3 ± 1.0 nm, n = 94 vesicles; ANOVA p > 0.05). Excess γ-
synuclein and NTD also increased the number of cisternal structures 
compared with controls (Figure 4F; GST: 1.5 ± 0.4 cisternae, n = 13 
synapses, 2 axons; GST-synuclein: 4.1 ± 0.6 cisternae, n = 35 syn-
apses, 3 axons; GST-synuclein NTD: 2.7 ± 0.5 cisternae, n = 13 syn-
apses, 2 axons; ANOVA p < 0.05). Both γ-synuclein and NTD in-
duced the appearance of unusually large cisternae (>1000 nm), 
which were not observed at control synapses (Figure 4G). As a result 
of inducing more and larger cisternae, full length γ-synuclein and 
NTD caused a significant fourfold increase in the total amount of 
membrane trapped within cisternae (Figure 4H; GST: 0.5 ± 0.1 μm, 
n = 13 synapses, 2 axons; GST-synuclein: 2.2 ± 0.3 μm, n = 35 syn-
apses, 3 axons; GST-synuclein NTD: 2.2 ± 0.5 μm, n = 13 synapses, 
2 axons; ANOVA p < 0.005). Thus, at synapses stimulated at high 
frequency, lamprey γ-synuclein and NTD induced a dramatic deple-
tion of synaptic vesicle membrane, paralleled by an increase in 
membrane trapped within atypical cisternae.
During stimulation, synaptic vesicles fuse with the plasma mem-
brane before being locally recycled via one of several endocytic 
pathways (Heuser and Reese, 1973; Slepnev and De Camilli, 2000; 
Clayton and Cousin, 2009; Wenzel et al., 2012; Morgan et al., 
2013a). The phenotype observed with excess γ-synuclein and NTD 
is consistent with a disruption in synaptic vesicle recycling, which 
results in a loss of synaptic vesicles concomitant with an expansion 
of the plasma membrane and/or an increase in endocytic intermedi-
ates (Shupliakov et al., 1997; Morgan et al., 2000, 2004; Andersson 
et al., 2008; von Kleist et al., 2011). To better understand the nature 
of the endocytic defect, we needed to determine the origin of the 
cisternae. The fact that there were clathrin-coated pits budding 
from the cisternae suggested that they might be derived from the 
plasma membrane (Figure 4, B–D). To test this, we systematically 
traced 36 cisternae through serial sections of synapses treated with 
excess full-length lamprey γ-synuclein (n = 20 synapses). Of the 
cisternae that could be reliably traced back to their origins, 83% 
(30/36) were still connected to the plasma membrane (Figure 5), 
while only 17% (6/36) were separated from the plasma membrane. 
Thus, at the time of fixation, the vast majority of cisternae were still 
connected to the plasma membrane, indicating that they are plasma 
membrane extensions. Lending further support to this idea, plasma 
membrane evaginations were 45% larger at synapses treated with 
NTD, which is consistent with the greater loss of synaptic vesicles 
observed in this condition (Figure 4I; GST: 2.0 ± 0.1 μm, n = 13 syn-
apses, 2 axons; GST-synuclein: 2.2 ± 0.1 μm, n = 34 synapses, 3 ax-
ons; GST-synuclein NTD: 2.9 ± 0.3 μm, n = 12 synapses, 2 axons; 
ANOVA p < 0.01). The number of clathrin-coated pits and vesicles 
observed at synapses with excess synuclein or NTD was not signifi-
cantly different from controls (Figure 4J; GST: 3.1 ± 0.8 clathrin 
coats, n = 13 synapses, 2 axons; GST-synuclein: 1.6 ± 0.4 clathrin 
FIGURE 3: Excess synuclein does not affect synaptic vesicle 
clustering at unstimulated synapses. (A) Experimental paradigm 
used in this study. Giant RS axons were microinjected with excess 
recombinant synuclein. This was followed by immediate fixation 
either without stimulation or after stimulation with action 
potentials. Inset shows how the proteins gain access to the 
presynaptic vesicle clusters. (B) Diagram of the recombinant 
proteins that were injected. (C–F) Electron micrographs of 
unstimulated giant RS synapses after no injection (Control) or after 
injection of GST (GST), full-length lamprey γ-synuclein (Synuclein), 
or its NTD (Synuclein-NTD). In all cases, the synaptic vesicle (SV) 
clusters are large and appear normal. Asterisks mark the 
postsynaptic dendrites. Dotted lines indicate the plasma 
membrane. Scale bar in C applies to panels C–F. (G) The number 
of SVs was not significantly different across any of these 
conditions. Bars represent mean ± SEM from n = 8–13 synapses, 
2 axons. n.s., not significant by ANOVA.
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increase in the number of cisternae at synapses (see Figure 8G), 
and nearly 25% of them were > 1000 nm in circumference 
(see Figure 8H). Furthermore, the total amount of membrane 
trapped within cisternae increased 3.4-fold (see Figure 8I; control: 
0.7 ± 0.1 μm, n = 45 synapses, 4 axons; α-synuclein: 2.2 ± 0.4 μm, 
n = 22 synapses, 2 axons; ANOVA p < 0.00005). With α-synuclein, 
92% of the cisternae were still connected to the plasma membrane 
(34/37; n = 18 synapses; Figure 6, D–G). Reconstructions of serial 
electron micrographs showed that the cisternae induced by α-
synuclein were larger than those at control synapses and that they 
were still connected to the plasma membrane in at least one sec-
tion, once again indicating that these structures are predominantly 
extensions of the plasma membrane (Figure 6, H and I, arrow-
heads). In addition, plasma membrane evaginations increased by 
55% in the presence of α-synuclein, relative to controls (Figure 6, 
H and I; see Figure 8J; control: 2.0 ± 0.08 μm, n = 44 synapses, 
4 axons; α-synuclein: 3.1 ± 0.17 μm, n = 21 synapses, 2 axons; 
ANOVA p < 0.001). Interestingly, human α-synuclein also caused a 
significant twofold increase in the total number of clathrin-coated 
pits and vesicles, suggesting effects on clathrin-mediated synaptic 
vesicle recycling (see Figure 8K; control: 1.7 ± 0.3 clathrin coats, 
n = 44 synapses, 4 axons; α-synuclein: 3.5 ± 0.4 clathrin coats, 
n = 22 synapses, 2 axons; ANOVA p < 0.0001). Thus, as with lam-
prey γ-synuclein, excess human α-synuclein inhibited synaptic 
vesicle recycling, indicating functional conservation between the 
synuclein orthologues.
coats, n = 35 synapses, 3 axons; GST-synuclein NTD: 5.2 ± 0.8 clath-
rin coats, n = 13 synapses, 2 axons; ANOVA p < 0.0005). Taken to-
gether, these data indicate that excess lamprey γ-synuclein inhibits 
synaptic vesicle recycling from the plasma membrane during in-
tense stimulation.
Excess human α-synuclein also impairs synaptic vesicle 
recycling, indicating functional conservation
The fact that the highly conserved NTD of lamprey γ-synuclein was 
sufficient to reproduce the endocytic phenotype suggested that 
other synuclein orthologues would have similar effects. We there-
fore tested the effects of excess human α-synuclein on synaptic 
vesicle trafficking. Buffer was injected as a negative control. Excess 
human α-synuclein also reduced the number of synaptic vesicles 
and increased cisternae and plasma membrane evaginations at 
synapses during high-frequency stimulation (20 Hz, 5 min; Figure 
6, A, B, H, and I). The number of synaptic vesicles was significantly 
reduced by 78% relative to controls (see Figure 8F later in this ar-
ticle) (control: 136 ± 10 SVs/section, n = 44 synapses, 4 axons; hu-
man α-synuclein: 30 ± 4 SVs/section, n = 22 synapses, 2 axons; 
ANOVA p = 5.4 × 10−11). The diameter of the remaining synaptic 
vesicles was not significantly changed (control: 52.4 ± 0.4 nm, n = 
200 vesicles; α-synuclein: 51.3 ± 0.6 nm, n = 200 vesicles; t test 
p = 0.12). Large, irregularly shaped cisternae, both vesicular and 
tubular, were also observed with excess human α-synuclein (Figure 
6, B and C). Excess α-synuclein caused a significant twofold 
FIGURE 4: Excess lamprey γ-synuclein inhibits synaptic vesicle recycling during intense stimulation. (A–C) Electron 
micrographs of stimulated (20 Hz, 5 min) RS synapses after treatment with GST alone, full-length γ-synuclein, or the 
NTD. In the GST controls, large synaptic vesicle (SV) clusters were visible, and plasma membrane extensions (dotted 
lines) were modest, owing to efficient SV recycling. In contrast, after treatment with synuclein or NTD, the number of 
vesicles was greatly reduced, and large cisternae (C) were apparent, indicating a defect in SV recycling. Cisternae often 
had clathrin-coated pits emanating from them (circles), suggesting they derived from the plasma membrane. Asterisks 
indicate postsynaptic dendrites. Scale bar in panel A applies to A–C. (D) Examples of cisternae after treatment with 
excess lamprey γ-synuclein. (E–J) Quantification of the endocytic defects produced by lamprey synuclein. Synuclein 
reduced the number of SVs at synapses (E) and increased the amount of membrane trapped in cisternae (F–H). 
Synuclein NTD additionally increased the size of plasma membrane evaginations (I). Changes in clathrin coats were not 
significant (J). Bars represent mean ± SEM from n = 13–35 synapses, 2–3 axons. Asterisks indicate statistical significance 
from GST controls by ANOVA (Tukey’s post hoc p < 0.05).
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Mutations that disrupt the α-helix of α-synuclein greatly 
reduce the endocytic defects
Our results here and in a prior study suggest that the highly con-
served NTD is responsible for the synaptic vesicle–trafficking de-
fects (Nemani et al., 2010). However, no structure–function analysis 
has been performed to determine which feature of the NTD is caus-
ing the defects, and we therefore set out to determine this. It is well 
established that the NTDs of synucleins fold into an amphipathic 
α-helix upon binding to acidic phospholipids within small vesicles 
(Davidson et al., 1998; Perrin et al., 2000; Chandra et al., 2003). Us-
ing circular dichroism and nuclear magnetic resonance (NMR) analy-
ses, several mutations in the NTD have been identified that signifi-
cantly reduce the α-helical content of the protein (Perrin et al., 2000; 
Ulmer and Bax, 2005). One is “A30P,” a missense mutation in which 
A30 is mutated to a proline, which is found in some familial PD pa-
tients (Figure 7A; Perrin et al., 2000; Ulmer and Bax, 2005). Though 
only a point mutation, A30P causes one turn of the α-helix to adopt 
an extended conformation and in doing so destabilizes the sur-
rounding turns and induces a large stretch of the amphipathic α-
helix to fall out of register (Ulmer and Bax, 2005). The other is a 
synthetic mutant, “T6K,” in which six threonines lying along the hy-
drophobic face of the amphipathic α-helix are mutated to lysines 
(i.e., T22K, T33K, T44K, T59K, T81K, T92K; Figure 7A; Perrin et al., 
2000). With both mutants, the α-helical content is only about half of 
that observed for wild-type α-synuclein (Perrin et al., 2000). We used 
a liposome flotation assay to determine how well these mutants still 
bind to the acidic phospholipid, PA (Burre et al., 2010, 2012). In this 
assay, small, sonicated liposomes (25–30 nm) primarily float up into 
the top two fractions of an Accudenz gradient upon centrifugation. 
Thus any liposome-bound protein will appear in these fractions, 
while unbound, free protein will remain in the lower fractions (Figure 
7B). As expected, wild-type α-synuclein bound strongly to lipo-
somes containing PC/PA, but not to those containing only PC (Figure 
7, C and D; n = 3). In comparison, A30P and T6K still bound robustly 
to PC/PA liposomes, but with reduced affinity (Figure 7, C and D; 
n = 3). Thus T6K and A30P disrupt the α-helical conformation of 
α-synuclein but retain significant lipid-binding capacity, corroborat-
ing previous observations (Perrin et al., 2000; Bussell and Eliezer, 
2004; Burre et al., 2012).
To determine the extent to which the α-synuclein–associated en-
docytic defects are influenced by changes in the α-helical content 
of the protein, we tested the effects of T6K and A30P on vesicle 
trafficking. Surprisingly, stimulated synapses treated with either T6K 
or A30P appeared more similar to control synapses than to syn-
apses treated with wild-type α-synuclein (Figure 8, A–E). With both 
mutants, the synaptic vesicle clusters were much larger than at syn-
apses treated with wild-type α-synuclein, and in the case of A30P, 
the vesicle clusters were indistinguishable from controls (Figure 8F; 
control: 136 ± 10 SVs/section, n = 44 synapses, 4 axons; α-synuclein: 
30 ± 4 SVs/synapse, n = 22 synapses, 2 axons; T6K: 75 ± 9 SVs/
synapse, n = 28 synapses, 2 axons; A30P: 148 ± 16 SVs, n = 24 syn-
apses, 2 axons; ANOVA p = 5.4 × 10–11). The number of cisternal 
structures was still increased with T6K and A30P (Figure 8G; control: 
1.6 ± 0.2 cisternae, n = 44 synapses, 4 axons; α-synuclein: 3.1 ± 0.6 
cisternae, n = 22 synapses, 2 axons; T6K: 3.0 ± 0.5 cisternae, n = 28 
synapses, 2 axons; A30P: 2.6 ± 0.5 cisternae, n = 24 synapses, 
2 axons; ANOVA p < 0.05). However, the cisternae observed in the 
FIGURE 5: Cisternae caused by excess lamprey γ-synuclein are often 
connected to the plasma membrane. (A–D) Serial electron 
micrographs through a stimulated RS synapse treated with lamprey 
γ-synuclein. In A, a single cisterna (C) appears to be disconnected 
from the plasma membrane. However, in B, the cisterna is contiguous 
with the plasma membrane (arrows), indicating that it is an extension 
of the plasma membrane. In C and D, the cisterna is no longer 
distinguishable from the plasmalemma. SVs, synaptic vesicles. 
Asterisks mark the postsynaptic dendrite. Scale bar in panel A applies 
to A–D. (E) Left, a large cisterna that has several clathrin-coated pits 
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with T6K and A30P (Figure 8J; control: 2.0 ± 0.1 μm, n = 44 syn-
apses, 4 axons; α-synuclein: 3.1 ± 0.2 μm, n = 21 synapses, 2 axons; 
T6K: 2.9 ± 0.2 μm, n = 28 synapses, 2 axons; A30P: 2.5 ± 0.2 μm, 
n = 24 synapses, 2 axons; ANOVA p < 0.001). Clathrin-coated pits 
and vesicles were still elevated with T6K, but were similar to control 
values with A30P (Figure 8K; control: 1.7 ± 0.3 clathrin coats, n = 44 
synapses, 4 axons; α-synuclein: 3.5 ± 0.4 clathrin coats, n = 22 syn-
apses, 2 axons; T6K: 3.8 ± 0.5 clathrin coats, n = 28 synapses, 
2 axons; A30P: 1.8 ± 0.4 clathrin coats, n = 24 synapses, 2 axons; 
ANOVA p < 0.0001). Thus the T6K and A30P mutations within the 
presence of T6K and A30P were the small, vesicular type normally 
observed in controls, and they did not exhibit obvious connections 
to the plasma membrane (Figure 8, C–E and H). The total amount of 
membrane within cisternae after T6K and A30P was significantly 
reduced in comparison with wild-type α-synuclein (Figure 8I; control: 
0.7 ± 0.1 μm, n = 45 synapses, 4 axons; α-synuclein: 2.2 ± 0.4 μm, 
n = 22 synapses, 2 axons; T6K: 1.1 ± 0.2 μm, n = 28 synapses, 
2 axons; A30P: 1.2 ± 0.3 μm, n = 24 synapses, 2 axons; ANOVA p < 
0.00005). Paralleling the recovery of synaptic vesicles and cisternae, 
the plasma membrane evaginations were also progressively smaller 
FIGURE 6: Excess human α-synuclein also inhibits synaptic vesicle recycling during intense stimulation. 
(A and B) Electron micrographs of stimulated RS synapses (20 Hz, 5 min) treated with buffer only (Control) or wild-type 
human α-synuclein. At control synapses, large synaptic vesicle (SV) clusters were visible, and plasma membrane 
evaginations (dotted lines) were modest because of efficient synaptic vesicle recycling. In contrast, after treatment of 
synapses with human α-synuclein, there were fewer SVs, cisternae were apparent, and plasma membrane evaginations 
were greatly expanded. Asterisks mark postsynaptic dendrites. C, cisterna. Circles, clathrin-coated pits or vesicles. Scale 
bar in A applies to B. (C) Cisternae caused by excess human α-synuclein. (D–G) Electron micrographs showing the 
connections between the cisternae and plasma membrane (arrows). (H and I) Three-dimensional reconstructions of 
stimulated RS synapses treated with buffer (control) or with excess human α-synuclein. The control synapse exhibits a 
large cluster of synaptic vesicles (blue) at the active zone (red), a relatively flat presynaptic plasma membrane (green), 
and small, infrequent cisternae (magenta). In contrast, after excess human α-synuclein, there were only a few synaptic 
vesicles, very large plasma membrane evaginations, and several larger, atypical cisternae. Most large cisternae were 
connected to the plasma membrane in at least one section (arrowheads). Scale bar in H applies to I.
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NTD greatly reduced the endocytic defects caused by excess hu-
man α-synuclein, indicating that a properly folded α-helix is a major 
structural determinant underlying the synaptic vesicle trafficking 
defects induced by excess α-synuclein.
The A53T α-synuclein mutant also impairs synaptic vesicle 
recycling
If a properly folded α-helix is responsible for causing the synaptic 
vesicle recycling defects observed with excess α-synuclein, then 
other mutants that retain the α-helical conformation should similarly 
affect vesicle recycling. One such mutant is A53T, another PD-linked 
mutation in α-synuclein, which exhibits normal lipid-induced α-
helicity (Perrin et al., 2000). As predicted by the model, excess A53T 
caused a phenotype that was nearly identical to that induced by 
wild-type α-synuclein (Figure 9). The number of synaptic vesicles 
was significantly reduced (Figure 9, A–F; control: 87 ± 7 SVs/section, 
n = 35 synapses, 2 axons; A53T: 35 ± 8 SVs/section, n = 25 synapses, 
2 axons; Student’s t test p < 0.001). The number of cisternae increased 
(Figure 9G; control: 0.4 ± 0.1 cisternae, n = 35 synapses, 2 axons; 
A53T: 2.9 ± 0.4 cisternae, n = 25 synapses, 2 axons; Student’s t test 
p < 0.5 × 10−8). As with wild-type α-synuclein, A53T shifted the distri-
bution of cisternae toward larger sizes such that ∼25% of the cister-
nae were >1000 nm in circumference (Figure 9H). With A53T, the 
total amount of membrane within cisternae increased significantly 
(Figure 9I; control: 0.2 ± 0.1 μm, n = 35 synapses, 2 axons; A53T: 3.0 
± 0.5 μm, n = 25 synapses, 2 axons; Student’s t test p < 0.05 × 10−6). 
Furthermore, the size of plasma membrane evaginations was in-
creased (Figure 9J; control: 2.1 ± 0.1 μm, n = 35 synapses, 2 axons; 
A53T: 3.0 ± 0.3 μm, n = 25 synapses, 2 axons; Student’s t test 
p < 0.001). A53T also increased the number of clathrin-coated pits 
and vesicles ∼twofold (Figure 9K; control: 2.3 ± 0.9 clathrin coats, 
n = 35 synapses, 2 axons; A53T: 5.4 ± 1.9 clathrin coats, n = 25 syn-
apses, 2 axons; Student’s t test p < 0.0005). Thus A53T phenocopied 
the endocytic defects observed with excess wild-type α-synuclein, 
further corroborating that a properly folded α-helix is the major struc-
tural determinant underlying the synaptic vesicle recycling defects.
Excess α-synuclein does not impair synaptic vesicle recycling 
evoked by lower-frequency stimulation
The high-frequency stimulation used in these experiments is known 
to evoke activity-dependent bulk endocytosis at synapses, in addi-
tion to clathrin-mediated endocytosis (Clayton and Cousin, 2009; 
Wenzel et al., 2012). In contrast, lower-frequency stimulation (5 Hz 
or less) appears to evoke predominantly clathrin-mediated synaptic 
vesicle recycling at lamprey RS synapses (Shupliakov et al., 1997; 
Ringstad et al., 1999). To further probe the mode(s) of endocytosis 
being affected by excess α-synuclein, we used a milder stimulation 
paradigm. After stimulation at 5 Hz for 30 min, synapses treated 
with excess human α-synuclein appeared very similar to control syn-
apses (Figure 10, A–D). Quantification revealed that there was no 
significant difference in the number of synaptic vesicles (Figure 10E; 
control: 154 ± 14 SVs/section, n = 22 synapses, 2 axons; α-synuclein: 
131 ± 12 SVs/section, n = 20 synapses, 2 axons; Student’s t test 
p = 0.22). Changes in the number of cisternae and their size distribu-
tion were unremarkable (Figure 10, F and G; control: 2.5 ± 0.6 cister-
nae; α-synuclein: 3.5 ± 0.7 cisternae; Student’s t test p = 0.31). In 
both controls and α-synuclein–treated synapses, the cisternae were 
generally the small, vesicular type (Figure 10, C and D). The total 
amount of membrane in the cisternae was not significantly altered 
(Figure 10H; control: 1.0 ± 0.2 μm; α-synuclein: 1.8 ± 0.5 μm; 
Student’s t test p = 0.09). Neither was the average size of plasma 
membrane evaginations significantly changed (Figure 10I; control: 
FIGURE 7: α-Synuclein mutations A30P and T6K alter proper folding 
of the N-terminal α-helix. (A) Wild-type (WT) human α-synuclein and 
mutants. A30P and T6K exhibit significantly reduced α-helical content 
in the NTD, based on circular dichroism analysis (Perrin et al., 2000). 
Asterisks mark the locations of the mutations. (B) Liposome flotation 
assay. Liposomes (circles), and thus bound protein (bars), are 
predominantly in the top two fractions after centrifugation, while 
unbound protein is in the lower fractions, where the percentage of 
liposomes is low. The data in the graph show an example of 
fluorescence measurements from NBD-labeled PC liposomes. (C) WT 
α-synuclein binds to PC/PA liposomes but not to PC alone. T6K and 
A30P also bind to PC/PA liposomes, but with reduced affinity, 
confirming previous observations (Perrin et al., 2000). (D) Quantification 
of data from liposome-binding assays showing α-synuclein and mutants 
binding to PC and PC/PA. Data points represent mean ± SEM from 
n = 3 independent experiments.
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exocytosis (Larsen et al., 2006; Gaugler et al., 2012; Lundblad et al., 
2012), others reported impairment of vesicle reclustering after en-
docytosis (Nemani et al., 2010) or pleiotropic effects (Scott et al., 
2010). With chronic overexpression, it is difficult to assess which 
vesicle trafficking defects are due to excess α-synuclein because of 
the decreased expression levels of other presynaptic proteins, in-
cluding those involved in exocytosis, endocytosis, and vesicle clus-
tering (Nemani et al., 2010; Scott et al., 2010). Thus the direct ef-
fects of excess synuclein on synaptic vesicle trafficking remained 
unclear until now.
1.9 ± 0.1 μm; α-synuclein: 2.2 ± 0.2 μm; Student’s t test p = 0.07), 
and the number of clathrin-coated structures was similar (Figure 10J; 
control: 3.7 ± 0.6 clathrin coats; α-synuclein: 3.2 ± 0.7 clathrin coats; 
Student’s t test p = 0.56). Thus excess α-synuclein only impairs syn-
aptic vesicle recycling evoked during high-frequency stimulation.
DISCUSSION
To date, there have been conflicting reports about the stages in the 
synaptic vesicle trafficking pathway that are perturbed by α-synuclein 
overexpression. While some studies reported primary defects in 
FIGURE 8: Endocytic defects caused by excess human α-synuclein require proper folding of the N-terminal α-helix. 
(A and B) T6K and A30P greatly reduced the synaptic vesicle recycling defects after 20-Hz, 5-min stimulation. Synaptic 
vesicle (SV) clusters were larger, and the cisternae were less prevalent than with WT α-synuclein (see Figure 6). Asterisks 
mark the postsynaptic dendrites. Dotted lines indicate the plasma membrane. C, cisterna; circles, clathrin-coated pits or 
vesicles. Scale bar in A applies to B. (C) The cisternae observed with excess T6K (top) or A30P (bottom) were smaller 
and discontinuous with the plasma membrane (see D and E). (D and E) Three-dimensional reconstructions of stimulated 
RS synapses treated with T6K and A30P do not exhibit major endocytic defects but instead appear more similar to 
controls (compare with Figure 6H). Scale bar in D applies to E. (F–K) Quantification of the ultrastructural analyses. 
Consistent with an inhibition in synaptic vesicle recycling, wild-type α-synuclein decreased the number of synaptic 
vesicles (F), while increasing the number of cisternae (G), the frequency of large cisternae (H), the amount of membrane 
trapped within cisternae (I), and the size of plasma membrane evaginations (J). The increase in clathrin-coated pits and 
vesicles with α-synuclein also indicates vesicle recycling defects (K). In contrast, the T6K and A30P mutations reduced all 
aspects of the vesicle recycling defects associated with α-synuclein. Bars represent mean ± SEM from n = 22–44 
synapses, 2–4 axons. Asterisks indicate statistical significance by ANOVA (Tukey’s post hoc p < 0.05).
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endocytic defect. The impairment of endocytosis was activity de-
pendent, phenotypically conserved between lamprey γ-synuclein 
and human α-synuclein, and dependent upon a properly folded α-
helix in the NTD. While the acute perturbation strategy is better for 
revealing direct effects of excess synuclein on synaptic vesicle 
trafficking, we acknowledge that chronic overexpression of α-
synuclein more closely models what occurs in PD. In that respect, it 
is interesting to note that there are some strong similarities between 
the synaptic phenotypes observed after acute or chronic overex-
pression of α-synuclein. Similar to our findings, after overexpression 
By utilizing acute perturbations, we were able to overcome these 
limitations and examine the effects of excess synuclein on vesicle 
trafficking within a few minutes of its introduction to synapses, by-
passing the types of molecular compensation that occur with chronic 
overexpression. Our data revealed that excess α-synuclein dramati-
cally impaired synaptic vesicle recycling from the plasma membrane, 
as evidenced by a loss of synaptic vesicles and an expansion of the 
plasma membrane. Excess synuclein also increased the amount of 
membrane trapped within cisternae, the vast majority of which were 
still connected to the plasma membrane, further corroborating the 
FIGURE 9: A53T also impairs synaptic vesicle recycling evoked by high-frequency stimulation. (A and B) Compared with 
control synapses, A53T caused a reduction in the number of synaptic vesicles (SVs) and expansion of the plasma 
membrane (dotted lines) after 20-Hz, 5-min stimulation. Large cisternae were also apparent. C, cisterna; circles, 
clathrin-coated pits or vesicles. Scale bar in A applies to B. (C) Cisternae caused by A53T. (D and E) Three-dimensional 
reconstructions show the endocytic phenotype caused by A53T. A large cisterna was connected to the plasma 
membrane (arrowhead). Scale bar in D applies to E. (F–K) Synapses treated with A53T induced the same phenotype as 
wild-type α-synuclein: a reduction in synaptic vesicles (F); an increase in the number, size, and amount of membrane 
within cisternae (G–I); an increase in plasma membrane evaginations (J); and an increase in the number of clathrin-
coated pits and vesicles (K). Bars represent mean ± SEM from n = 25–35 synapses, 2 axons. Asterisks indicate statistical 
significance by Student’s t test (p < 0.05).
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Furthermore, our data suggest that excess 
α-synuclein affects several modes of synap-
tic vesicle recycling via both clathrin-medi-
ated endocytosis and activity-dependent 
bulk endocytosis (Figure 11). One predomi-
nant mechanism for recycling synaptic vesi-
cles is clathrin-mediated endocytosis 
(Granseth et al., 2006; Heerssen et al., 2008; 
Saheki and De Camilli, 2012). The increased 
number of clathrin-coated pits and vesicles 
we observed after acutely introducing ex-
cess α-synuclein is indicative of an effect on 
clathrin-mediated synaptic vesicle recycling. 
Why lamprey γ-synuclein did not alter clath-
rin-coated structures is not clear, but one 
possibility is that this is due to differences in 
the amino acid sequence, for example, in 
the C-terminal domain. Excess α-synuclein 
also appeared to inhibit activity-dependent 
bulk endocytosis, which is triggered at high 
frequencies (>10 Hz; Clayton et al., 2008; 
Cousin, 2009; Wenzel et al., 2012; Morgan 
et al., 2013a). In support of this, the endo-
cytic phenotype was unremarkable when 
the stimulation was lowered to 5 Hz, a con-
dition that normally does not evoke a lot of 
activity-dependent bulk endocytosis at syn-
apses. Further experiments are needed to 
determine whether the effects on clathrin-
mediated synaptic vesicle recycling are di-
rect, for example, through an interaction 
between α-synuclein and clathrin coat com-
ponents, or whether they are an indirect 
consequence of inhibiting activity-depen-
dent bulk endocytosis. Recent evidence 
from synuclein triple-knockout mice demon-
strated that synucleins participate in early 
stages of clathrin-mediated synaptic vesicle 
recycling, suggesting that a direct effect is 
possible (Vargas et al., 2014).
We estimated the amount of injected α-
synuclein to be 6–20 μM, a concentration 
range that in theory could induce a variety 
of synaptic phenotypes. However, we did 
not observe any obvious differences or 
trends in the phenotypes caused by excess 
α-synuclein or the mutants across the axonal 
region studied. That is, an endocytic pheno-
type was observed at the vast majority of 
α-synuclein– and A53T-treated synapses, 
and a drastic reduction of the endocytic phenotype was observed at 
the A30P- and T6K-treated synapses, regardless of the distance 
from the injection site. This indicates that a range of phenotypes 
was not lumped together across a steep dose–response curve. 
However, it should be mentioned that, with acute or chronic overex-
pression, it is simply not possible to know the precise concentration 
of protein that reaches the synapse in a functional state. This would 
seem particularly true for a protein like α-synuclein, which binds with 
high affinity to a variety of lipids and cellular membranes (Maroteaux 
et al., 1988; Davidson et al., 1998; Nakamura, 2013). Recent studies 
have reported multiple pools of α-synuclein at synapses after over-
expression: soluble, vesicle-bound, and aggregated forms (Spinelli 
of α-synuclein in mammalian neurons, the density of vesicles is de-
creased within synaptic boutons (Scott et al., 2010). In addition, ab-
normally large vesicular structures are apparent (Scott et al., 2010; 
Boassa et al., 2013). We would now interpret those large vesicular 
structures to be cisternae, caused by an impairment of endocytosis. 
Similar phenotypes have been reported at dopaminergic synapses 
after α-synuclein overexpression (Gaugler et al., 2012).
While we cannot completely rule out any defects in exocytosis, 
our data are most consistent with excess α-synuclein inhibiting syn-
aptic vesicle recycling. The decrease in synaptic vesicles and expan-
sion of the plasma membrane are classically representative of endo-
cytic defects (Morgan et al., 2000, 2004; Andersson et al., 2008). 
FIGURE 10: α-Synuclein does not affect synaptic vesicle recycling evoked by lower frequency 
stimulation. (A and B) Following a lower-frequency stimulation (5 Hz, 30 min), synapses treated 
with excess human α-synuclein appeared similar to control synapses. No endocytic phenotype 
was observed. Dotted lines indicate plasma membrane. SVs, synaptic vesicles; circles, clathrin-
coated pits or vesicles. Asterisks mark the postsynaptic dendrites. Scale bar in A applies to B. 
(C and D) Three-dimensional reconstructions of control and α-synuclein treated synapses after 
5-Hz, 30-min stimulation. No obvious differences were observed. (E–J) Quantification revealed 
that there was no significant change in the number of synaptic vesicles (E); the number, 
size distribution, or amount of membrane within cisternae (F–H); the size of plasma 
membrane evaginations (I); or the number of clathrin coats (J). Bars represent mean ± SEM 
from n = 20–22 synapses, 2 axons. n.s., not significant by Student’s t test (p > 0.05).
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vesicle clusters (Fortin et al., 2005), likely because of its reduced α-
helicity and lipid binding. Though this is speculative, one possibility 
is that A30P may cause fewer or delayed synaptic defects in hu-
mans, since this mutation exhibits incomplete penetrance (Kruger 
et al., 1998).
Whether excess α-synuclein exacerbates the normal function of 
synuclein or causes a neurotoxic gain of function at synapses is still 
an open question. A limiting factor is the lack of deep understand-
ing of α-synuclein’s normal function (Bendor et al., 2013). Early 
studies showed that knockdown of α-synuclein altered synaptic 
morphology in ways consistent with a role in vesicle trafficking 
(Murphy et al., 2000). Similarly, single and double synuclein knock-
outs (α, α/β, α/γ) exhibited defects in synaptic transmission, though 
the phenotypes reported were mild (Abeliovich et al., 2000; 
Chandra et al., 2004; Senior et al., 2008). However, some of the 
single and double knockouts induced an up-regulation of the re-
maining synuclein isoform(s) (Chandra et al., 2004). Recent studies 
have reinvestigated the normal roles for synucleins with the gen-
eration of synuclein triple-knockout mice (α/β/γ). The triple knock-
outs exhibited reduced formation of SNARE (Soluble NSF Attach-
ment Protein REceptor) complexes and reduced synaptic 
transmission, as well as altered presynaptic structure, supporting a 
normal role for synucleins in synaptic vesicle trafficking (Burre et al., 
2010; Greten-Harrison et al., 2010). Consistent with our model 
(Figure 11), a recent study places α-synuclein’s normal function at 
early stages of synaptic vesicle endocytosis (Vargas et al., 2014). 
Absence of synucleins (α/β/γ) slowed the kinetics of endocytosis 
and reduced the number of recycled synaptic vesicles (Vargas 
et al., 2014). Thus synuclein modulates synaptic vesicle recycling 
whether it is absent or in excess. This predicts that synaptic levels 
of α-synuclein should be tightly regulated in order to ensure proper 
vesicle recycling, which is consistent with the varied levels of synu-
clein observed at synapses (Fortin et al., 2005; Murphy et al., 2000). 
Further investigation of synuclein’s normal functions is warranted, 
as is a better understanding of how age-dependent changes in 
synuclein function at synapses impacts the pathobiology of PD and 
other synucleinopathies.
MATERIALS AND METHODS
Recombinant proteins
Cloning and expression of GST-tagged lamprey synucleins and un-
tagged human synucleins were as previously described (Perrin et al., 
et al., 2014), as well as tubule-bound forms (Boassa et al., 2013). In 
future synaptic studies, it will also be important to distinguish how 
much of the excess α-synuclein is localized to synaptic vesicles and 
cytosol versus the plasma membrane, mitochondria, clathrin-coated 
vesicles, and other synaptic membranes.
In addition to pinpointing the vesicle recycling defects caused by 
excess α-synuclein, this study is the first to delineate the structural 
mechanism. The first clue emerged when we discovered that the 
NTD of lamprey γ-synuclein was sufficient to reproduce the endo-
cytic defects. Similarly, the NTD of human α-synuclein was sufficient 
to produce the synaptic vesicle trafficking defects observed at mam-
malian synapses (Nemani et al., 2010). Among all synuclein ortho-
logues, the NTD is the most highly conserved region, predicting 
that it has an important function (George, 2002; Sun and Gitler, 
2008; Busch and Morgan, 2012). A structure–function analysis of α-
synuclein’s NTD allowed us to determine the underlying features 
causing the vesicle trafficking defects. The synthetic T6K mutant 
and the PD-linked A30P mutant both exhibit disrupted folding of 
the N-terminal α-helix while retaining significant lipid-binding ca-
pacity (Perrin et al., 2000; Ulmer and Bax, 2005; Burre et al., 2012). 
As a consequence of these mutations, excess α-synuclein no longer 
produced severe endocytic phenotypes and instead allowed synap-
tic vesicles to proceed fairly efficiently through the recycling path-
ways. Thus a properly folded α-helical domain within α-synuclein is 
a critical structural determinant underlying the endocytic defects. 
Further corroborating this idea, the PD-linked mutant A53T, with a 
properly folded α-helix, also exhibited the vesicle-recycling defects. 
How might this work? When in excess, a properly folded α-synuclein 
may bind and mask lipids that are critical for initiating vesicle reinter-
nalization from the plasma membrane, such as phosphoinositides 
(Figure 11) (Ford et al., 2001; Di Paolo et al., 2004). Alternatively, 
excess α-synuclein may bind and mislocalize or otherwise alter the 
functions of other endocytic proteins. Future experiments will deter-
mine the extent to which these mechanisms are in play.
The synaptic vesicle recycling defects produced by excess wild-
type α-synuclein and A53T are suggestive of the types of synaptic 
defects that could occur in patients with PD. At first, it may seem 
surprising that A30P failed to reproduce the endocytic defects, since 
A30P is also genetically linked to PD (Kruger et al., 1998). However, 
this result is consistent with previous studies in which A30P expres-
sion in mammalian neurons had no effect on synaptic transmission 
(Nemani et al., 2010). A30P also did not properly localize to synaptic 
FIGURE 11: Model for how excess α-synuclein impairs synaptic vesicle recycling. (A) Synaptic vesicle (SV) recycling with 
endogenous levels of synuclein. After calcium (Ca2+) influx and exocytosis, vesicles are efficiently recycled via local 
endocytosis from the plasma membrane. (B) With excess α-synuclein, SV recycling is disrupted, as evidenced by a loss 
of SVs and an expansion of the plasma membrane, which often buckled inward to create apparent cisternae. Excess 
α-synuclein inhibited at least two modes of synaptic vesicle recycling, clathrin-mediated and bulk endocytosis, but only 
during high-frequency stimulation. The working model is that excess α-synuclein, in its α-helical conformation, masks or 
mislocalizes key lipids or proteins necessary for initiating synaptic vesicle recycling.
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Immunofluorescence
All procedures involving lampreys were approved by the Institu-
tional Animal Care and Use Committees at the University of Texas at 
Austin (UT-Austin) and Marine Biological Laboratory (MBL) in accor-
dance with standards set by the National Institutes of Health (NIH). 
Late larval-stage sea lampreys (P. marinus; 11–13 cm) were anesthe-
tized with 0.1 g/l tricaine methanesulfonate (Finquel MS-222; 
Argent Laboratories; Redmond, WA). Spinal cords were then dis-
sected in oxygenated lamprey ringer containing (in mM) 100 NaCl, 
2.1 KCl, 2.6 CaCl2, 1.8 MgCl2, 4 glucose, 0.5 glutamine, 2 HEPES 
(pH 7.4), as previously described (Oliphint et al., 2010). Dissected 
spinal cords were fixed, cryoprotected, embedded in TissueTek 
OCT, cross-sectioned at 14 μm, and immunostained, as described 
by Oliphint et al. (2010). Primary antibodies used were a rabbit poly-
clonal pan-synuclein antibody (AbCam ab53726; Cambridge, MA) 
and a mouse monoclonal antibody against SV2 (DSHB; University of 
Iowa, Iowa City, IA). The SV2 antibody has been previously charac-
terized in vertebrates, including lampreys (Buckley and Kelly, 1985; 
Lau et al., 2011; Busch and Morgan, 2012). The synuclein antibody 
is characterized in the current study (Figures 1–2 and Supplemental 
Figure 1). Secondary antibodies used were: Alexa Fluor 488–conju-
gated goat–anti-rabbit IgGs and Alexa Fluor 594–conjugated goat–
anti-mouse IgGs (Life Technologies, Grand Island, NY). Confocal 
images were acquired with a Zeiss LSM Pascal Exciter on an 
Axioskop 2FS using a 40×, 1.3 NA EC Plan-Neofluar oil immersion 
objective. For images in Figure 2, E–G, an additional 3× digital zoom 
was applied. To quantify the colocalization of the immunofluores-
cence signals for synuclein and SV2, we used the ImageJ plug-in 
JACoP to calculate the Pearson’s correlation coefficients (n = 5 
images, 4 spinal cords; Bolte and Cordelieres, 2006; Dunn et al., 
2011).
Microinjections and stimulation
Microinjections were performed as previously described (Morgan 
et al., 2004, 2013b). Briefly, a 2- to 3-cm section of spinal cord was 
dissected and pinned ventral side up in a Sylgard-lined Petri dish 
containing oxygenated lamprey ringer (Figure 3A). All recombinant 
proteins were dialyzed into lamprey internal solution (180 mM KCl, 
10 mM HEPES, pH 7.4). Proteins (120–200 μM) were then loaded 
into glass microelectrodes and injected directly into giant RS axons 
using small pulses of N2 (5–20 ms, 30–50 psi, 0.1–0.3 Hz) delivered 
via a Toohey Spritzer. For estimating the axonal protein concentra-
tion, all proteins were coinjected with 100 μM fluorescein dextran 
(10 or 40 kDa, anionic, lysine fixable; Life Technologies). After 10–30 
min of injection, the axonal fluorescence reached 1/10th to 1/20th 
of that in the microelectrode. Therefore the estimated axonal con-
centration of the proteins was 6–20 μM. After injection, some spinal 
cords were immediately fixed without stimulation. In other experi-
ments, injected axons were stimulated intracellularly by action po-
tentials, using short, depolarizing current pulses, generated by an 
Axoclamp 2B amplifier (1 ms, 20–80 nA, 20 Hz for 5 min or 5 Hz for 
30 min). With the stimulation continuing, the spinal cords were fixed 
for electron microscopy using 3% glutaraldehyde, 2% paraformal-
dehyde in 0.1 M Na cacodylate (pH 7.4). Fixation occurred within 
5–10 s, as determined by the disappearance of action potentials.
Electron microscopy and morphometric analysis
Spinal cords were processed for electron microscopy as previously 
described (Oliphint et al., 2010; Morgan et al., 2013b). Spinal cords 
were postfixed with 2% osmium tetroxide containing 2% potassium 
ferrocyanide for 1.5 h on ice, stained en bloc with 2% uranyl acetate, 
dehydrated in an ethanol series, and embedded in Embed-812. 
2000; Busch and Morgan, 2012). An additional GST fusion compris-
ing only the NTD (aa 1–89) of lamprey γ-synuclein was also gener-
ated (GenBank: JN544525). Recombinant proteins were expressed 
in BL21-CodonPlus (DE3)-RILP Competent Cells (Agilent Technolo-
gies, Santa Clara, CA). GST fusion proteins were then purified using 
glutathione Sepharose beads (GE Healthcare, Pittsburgh, PA). Hu-
man α-synuclein and mutants were precipitated from the soluble 
protein fractions using ammonium sulfate, and the precipitate was 
resuspended in 20 mM sodium phosphate buffer (pH 7.4). α-
Synuclein and mutants were further purified using a Sepharose hy-
drophobic interaction column, followed by gel filtration on a Sep-
hacryl S-200 size-exclusion column and lyophilization. Proteins were 
resuspended or dialyzed into the appropriate buffer before each 
assay.
Western blotting
Western blotting was performed as previously described (Morgan 
et al., 2004; Busch and Morgan, 2012). Briefly, 0.5 μg of each re-
combinant protein was separated on a 10% SDS–polyacrylamide 
gel. For detecting endogenous proteins, 5 μg rat brain lysates and 
20 μg lamprey brain and spinal cord lysates were separated by 
SDS–PAGE. Proteins were transferred to nitrocellulose membranes, 
blocked with 5% dry milk, and then incubated with a rabbit poly-
clonal pan-synuclein antibody (AbCam ab53726; Cambridge, MA) 
at 1:1000 in TBST (20 mM Tris Base, pH 8.0, 137 mM NaCl, 0.1% 
Tween 20) for 1 h at room temperature (RT). Secondary antibody 
used was 1:4000 goat–anti-rabbit immunoglobulin G (IgG; Thermo 
Scientific, Waltham, MA). Western blots were developed using 
Thermo Scientific Pierce ECL substrates.
Vesicle binding assays
The vesicle binding assay shown in Figure 1G was performed as 
described previously for human α-synuclein (Davidson et al., 
1998; Perrin et al., 2000). Briefly, suvs were prepared from a mix-
ture of POPC and POPA (3:1) or pure POPC (Avanti Polar Lipids, 
Alabaster, AL), and incubated with recombinant GST-tagged 
lamprey synuclein for 2 h at a 20:1 mass ratio of lipid to protein. 
Samples were separated by gel exclusion chromatography 
(Superose 6); and peaks representing free protein, suv, and large 
multilamellar vesicles (mlv) were pooled and subjected to immu-
noblotting with anti-GST antibody (GeneTex GTX110736; Irvine, 
CA).
The liposome flotation assay in Figure 7 was performed as de-
scribed in previous studies (Burre et al., 2010, 2012). Liposomes 
comprising a mixture of POPC and NBD-labeled POPC (99:1) or 
a mixture of POPC, POPA, and NBD-POPC (49:50:1) (Avanti 
Polar Lipids, Alabaster, AL) were prepared and sonicated. Soni-
cated liposomes were then incubated with 5 μg α-synuclein (WT, 
T6K, or A30P) in HKE buffer (25 mM HEPES, pH 7.4, 150 mM KCl, 
1 mM EDTA) at RT for 2 h. Samples were then centrifuged at 
280,000 × g for 3 h at RT in an Accudenz gradient (Accurate 
Chemical and Scientific, Westbury, NY). Afterward, samples were 
separated into eight fractions. Fluorescence in each fraction was 
analyzed using a NanoDrop 3300 fluorospectrometer to deter-
mine which fractions contained the liposomes. The fractions were 
also analyzed by Western blotting to evaluate the bound versus 
free protein. Western blotting was as above, except that second-
ary antibody was used at 1:1000. Background-subtracted band 
intensity was measured using ImageJ. Then the band intensity for 
each fraction was calculated as a percentage of the sum total for 
each experiment, and data were averaged from n = 3 indepen-
dent experiments.
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Ultrathin sections (70 nm) were cut and counterstained with 2% ura-
nyl acetate and 0.4% lead citrate, after which individual synapses 
were imaged at 26,500× or 37,000×, respectively, using a Technai 
Spirit BioTwin T12 or JEOL JEM 200CX transmission electron micro-
scope. For each experimental condition, images of more than 10 
synapses were collected from at least two axons, and they were ac-
quired from the same region of the injected axon (25–150 μm from 
the injection site), ensuring that the protein concentration was 
comparable.
Morphometric analyses of presynaptic membranes were per-
formed in ImageJ by an experimenter blinded to the experimental 
condition. All synaptic vesicles were counted within a 1-μm radius of 
the active zone. Cisternae were defined as irregularly shaped, intra-
cellular membranous structures larger than 100 nm in diameter. Cis-
ternal size was determined by measuring the distance around the 
perimeter. “Total cisternae” was calculated by summing the total 
amount of membrane within individual cisternae per synapse. 
Plasma membrane evaginations were measured as previously de-
scribed (Morgan et al., 2004). A straight line (1 μm) was drawn later-
ally from the edge of the active zone to the nearest point on the 
axolemma, and then the curved distance between these two points 
was measured. After obtaining measurements from the right and 
left sides of the active zone, we recorded the average for each syn-
apse. Clathrin-coated pits and vesicles were distinguished by the 
presence of an electron-dense coat. All data shown in the graphs 
are reported as the mean ± SEM per synapse. Graphs and ANOVA 
statistics were generated using Origin Pro 7.0 (OriginLab, Northamp-
ton, MA).
Each of the three-dimensional reconstructions was generated 
from five serial sections using Reconstruct software (Fiala, 2005). 
First, the micrographs were aligned to each other using fiduciary 
markers. Next the cisternae, active zones, and plasma membranes 
were traced on each micrograph. Finally, the traces were recon-
structed as objects into a three-dimensional scene as either a trace 
slab or Boissonnat surface, and synaptic vesicles were reconstructed 
as 50-nm-diameter spheres.
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